TrialActa haematologica2024

The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group.

Drorit Merkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.